Cisatracurium Besilate

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 42 records

Cisatracurium Besilate 2 markets · 42 records Forms
Filters
MarketAU 41TW 1

AU 41 records · 12 shown of 15 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 2.68 mg/mL per mL / per unit basis not statedinjectionAPO-CISATRACURIUM cisatracurium (as besilate) 10 mg / 5 mL solution for injection ampouleCISATRACURIUM AJS cisatracurium (as besilate) 10mg/5mL injection solution in vial、Cisatracurium APOTEX cisatracurium (as besilate) 20 mg / 10 mL solution for injection ampoule、CISATRACURIUM MYLAN cisatracurium (as besilate) 10 mg/5 mL solution for injection vial、GenRx Cisatracurium cisatracurium (as besilate) 10 mg / 5 mL solution for injection ampoule、NIMBEX cisatracurium (as besilate) 5mg/2.5mL injection ampoule unknown
  • 13.4 mg per mL / per unit basis not statedinjectionCISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vialCISATRACURIUM MEDICIANZ cisatracurium (as besilate) 10 mg/5 mL injection ampoule、CISATRACURIUM MEDSURGE cisatracurium (as besilate) 10 mg/5 mL injection ampoule unknown
  • 6.7 mg per mL / per unit basis not statedinjectionCISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vialCISATRACURIUM MEDICIANZ cisatracurium (as besilate) 10 mg/5 mL injection ampoule、CISATRACURIUM MEDSURGE cisatracurium (as besilate) 10 mg/5 mL injection ampoule unknown
  • 6.7 mg/mL per mL / per unit basis not statedinjectionCISATRACURIUM AJS cisatracurium (as besilate) 10mg/5mL injection solution in vialNIMBEX cisatracurium (as besilate) 150mg/30mL injection vial unknown
  • 211.05 mg per mL / per unit basis not statedinjectionCISATRACURIUM JUNO cisatracurium besilate 150mg/30mL Solution for Injection vial unknown
  • 201 mg per mL / per unit basis not statedinjectionCISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vial unknown
  • 67 mg per mL / per unit basis not statedinjectionCISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vial unknown
  • 28.14 mg per mL / per unit basis not statedinjectionCISATRACURIUM JUNO cisatracurium (as besilate) 20mg/10mL Solution for Injection ampoule unknown
  • 26.8 mg per mL / per unit basis not statedinjectionCISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vial unknown
  • 26.77 mg per mL / per unit basis not statedinjectionCISATRACURIUM DEMOGEN cisatracurium (as besilate) 10 mg/5 mL solution for injection ampoule unknown
  • 14.07 mg per mL / per unit basis not statedinjectionCISATRACURIUM JUNO cisatracurium (as besilate) 20mg/10mL Solution for Injection ampoule unknown
  • 13.38 mg per mL / per unit basis not statedinjectionCISATRACURIUM DEMOGEN cisatracurium (as besilate) 10 mg/5 mL solution for injection ampoule unknown
Other strengths: 3 · 1 dosage forms Otras concentraciones: 3 · 1 formas farmacéuticas 其余规格 3 个 · 涉及 1 种剂型 其餘規格 3 個 · 涉及 1 種劑型
6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Cisatracurium Accord ×1CISATRACURIUM DEMOGEN ×1CISATRACURIUM JUNO ×1CISATRACURIUM MEDSURGE ×1Cisatracurium-AFT ×1NIMBEX ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.